Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease
CHEST · 2023
DOI: 10.1016/j.chest.2023.04.015 ↗Kurz gefasst
Leserbrief in der Zeitschrift CHEST, 2023. Verfasst von Roberto G Carbone und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Genoa, Genoa, Italy. Electronic address: magister1@mail.com. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Lung Diseases, Interstitial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Genoa, Genoa, Italy. Electronic address: magister1@mail.com.
- Clalit Health Services, Tel Aviv, Israel.
- Department of Internal Medicine, University of Genoa, Genoa, Italy.
Zitieren
APA
Carbone, R. G., Monselise, A., & Puppo, F. (2023). Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease. CHEST. https://doi.org/10.1016/j.chest.2023.04.015
Vancouver
Carbone RG, Monselise A, Puppo F. Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease. CHEST. 2023. doi:10.1016/j.chest.2023.04.015
BibTeX
@article{Carbone2023,
author = {Carbone, Roberto G and Monselise, Assaf and Puppo, Francesco},
title = {Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease},
journal = {CHEST},
year = {2023},
doi = {10.1016/j.chest.2023.04.015}
}
EUVIMED